Navigation Links
AstraZeneca Response to November 2, 2007 Ruling In Re: Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, U.S. District Court, District of Massachusetts
Date:11/2/2007

WILMINGTON, Del., Nov. 2 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) is disappointed with today's ruling and we intend to appeal. We believe the ruling is unsupported as the conduct at issue was the result of highly competitive conditions in the pharmaceutical marketplace, which led to discounting. The Court's prior ruling on liability is thus profoundly anti- competitive.

AstraZeneca has competed responsibly with respect to pricing and marketing of drugs and we firmly believe that we have acted at all times in accordance with the law.

The plaintiffs are fully aware of AWP pricing and still use AWP as a reimbursement benchmark today. The result of AstraZeneca's conduct in this case was to keep a lower cost product competitive under the Government's reimbursement system, thereby saving Medicare and patients millions of dollars.


'/>"/>
SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Astrazenecas Investigational Cancer Therapies Revealed at ASCO
2. Stress response increases suicide risk
3. Gene variation simulates cholesterol response to oestrogen
4. Alcohol injures stress hormone response
5. Self control makes stress response easy
6. Perceived stress decreases vaccine response
7. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
8. Harmful chemicals change the genetic response to hormone estrogen
9. Increasing Insulin Response In Type 2 Diabetics With New Protein Mixture
10. Sexes differ in response to burnout on the job and depression
11. Reflecting On Personal Values Can Lower Stress Responses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... ... personal financial planning to families and business owners in North Central West Virginia, ... help provide services to differently abled residents in the region. , The Stepping ...
(Date:6/22/2017)... , ... June 22, 2017 , ... Plastic Surgery Associates ... a Top Doctor for 2017. Each year, research and information firm, Castle Connolly, releases ... the title in 2015, this marks the 3rd time that Dr. Canales ...
(Date:6/22/2017)... Washington, DC (PRWEB) , ... June 22, 2017 ... ... awarded a $3.7 million grant from the American Heart Association (AHA) to launch ... economic incentives to improve the prevention and diagnosis of rheumatic heart disease (RHD) ...
(Date:6/22/2017)... ... 22, 2017 , ... Vighter, a premier provider of Unconventional ... ANSI/ASIS PSC.1-2012. The company’s work in countries throughout Southwest Asia, South America, and ... been degraded. The PSC.1 standard was created to protect fundamental freedoms and human ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, a ... Nashville-based private equity firm, has invested $3.35 million in the company. , ... Claritas Capital offers the smart money, speed to market and accountability we had ...
Breaking Medicine News(10 mins):
(Date:6/10/2017)... Ala. , June 9, 2017  Shane K. Burchfield, DPM, ... recognized for excellence as a Podiatrist in Alabama ... Podiatry at Family First Foot Care. He brings over 20 years ... medicine, pain management and healthcare, to his role. ... First Foot Care, PC is pleased to welcome you ...
(Date:6/8/2017)... June 8, 2017  Less than a month ago, ... than 200,000 companies, including hospital networks, in over 150 ... one of the largest online extortion attempts ever recorded. ... market, it is imperative that providers understand where the ... from this — and many other very real cyber ...
(Date:6/7/2017)... June 7, 2017 Endo International plc (NASDAQ: ... 2017, the Hon. Joseph R. Goodwin , U.S. ... West Virginia , entered a case management ... Repair System Products Liability Litigation (the "MDL") that includes ... to provide expert disclosures on specific causation within one ...
Breaking Medicine Technology: